Injectable Benzodiazepine Market (By Drug Class- Diazepam, Lorazepam, Midazolam. By Time of Action – Short Acting, Long Acting. By Indication – Agitation & Aggression, Anxiety, Alcohol Withdrawal, Muscle Spasm, Seizures, Tetanus, Sedation, Anesthesia, Insomnia, Status Epilepticus. By Distribution Channel – Hospitals, Ambulatory Surgical Centers, Diagnostics Centers. By Region – North America, Latin America, Middle East and Africa, Europe.) – Global industry analysis, size, share, growth, trends and forecast, 2020 – 2030.

The Global Injectable Benzodiazepine Market was valued at $7.1 Billion in 2020. Growing at a high CAGR of more than 7.9% between 2020 and 2030, it is estimated to reach $15.2 Billion by 2030. However this current COVID-19 pandemic may have made a slight difference in the growth rate in the present year. The primary reason for the growth of this market is the generic injectable Benzodiazepine drugs because these are most cost-effective. Those suffering from insomnia, seizures, anxiety are prescribed generic midazolam, lorazepam, diazepam drugs as these have been increased currently.

Global Injectable Benzodiazepine Market Is Estimated to Witness Remarkable Growth

Source: SAI Research

The Global Injectable Benzodiazepine Market has been segmented into drug class, indication, distribution channel, regions (By Drug Class- Diazepam, Lorazepam, Midazolam. By Time of Action – Short Acting, Long Acting. By Indication – Agitation & Aggression, Anxiety, Alcohol Withdrawal, Muscle Spasm, Seizures, Tetanus, Sedation, Anesthesia, Insomnia, Status Epilepticus. By Distribution Channel – Hospitals, Ambulatory Surgical Centers, Diagnostics Centers. By Region – North America, Latin America, Middle East and Africa, Europe.)

By Region, Asia Pacific Is Holding The Major Market Share

The Global Injectable Benzodiazepine Market has been geographically segmented into North America, Latin America, Europe, Spain, Middle East and Africa. In addition to this, Asia Pacific Global Injectable Benzodiazepine Market is holding the largest market share currently and is estimated to show highest compound annual growth rate in the upcoming forecasted period. Latin America is also becoming an important market due to the high rate of alcohol withdrawal for those suffering from anxiety disorders among the population.

Major Players in the Global Injectable Benzodiazepine Market 

Some of the major players in the Global Injectable Benzodiazepine Market include include F Hoffmann-La Roche Ltd, Akorn Inc, Taj Pharmaceuticals Ltd., Pfizer Inc., AdvaCare Pharma, Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd, Hameln Pharma Ltd., Hikma Pharmaceuticals, Intas Pharmaceuticals Limited, Sun Pharmaceuticals Ltd, Martin Dow,Troy Laboratories Pty Ltd., Dash Pharmaceuticals LLC

The Global Injectable Benzodiazepine Market Has Been Segmented Into:

GLOBAL INJECTABLE BENZODIAZEPINE MARKET, DRUG CLASS

• Diazepam
• Lorazepam
• Midazolam

GLOBAL INJECTABLE BENZODIAZEPINE MARKET, BY TIME OF ACTION

• Short Acting
• Long Acting

GLOBAL INJECTABLE BENZODIAZEPINE MARKET, BY INDICATION

• Agitation & Aggression
• Anxiety
• Alcohol Withdrawal
• Muscle Spasm
• Seizures
• Tetanus
• Sedation
• Anesthesia
• Insomnia
• Status Epilepticus

GLOBAL INJECTABLE BENZODIAZEPINE MARKET, BY DISTRIBUTION CHANNEL

• Hospitals
• Ambulatory surgical centres
• Diagnostics centres

GLOBAL INJECTABLE BENZODIAZEPINE MARKET, BY REGION

• North America
• USA
• Canada
• Mexico
• Rest of North America
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• India
• China
• Japan
• South Korea
• Rest of Asia Pacific
• Latin America, Middle East & Africa
• Brazil
• South Africa
• UAE
• Rest of LAMEA